About Oxalis Pharmaceuticals Private Limited
Data last updated:
Oxalis Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 May 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2012PTC143462. Its GSTIN is 27AABCO6569N1ZQ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vardhan Mahaveer Deshmane and Mina Mahavir Deshmane.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolhapur, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹2.09 Lakh (net margin 1.9%) and EBITDA of ₹13.52 Lakh (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years and 79% over five years.
As per MCA filings, the company has open charges of ₹4 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oxalispharmaceuticals.com.
Company details
Contact details
Oxalis Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra. Its website is oxalispharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressCs No 584/1A – 2 Ground Floor Gala No 2 (Office) 1st Lane E Ward Sh, Ahupuri, Kolhapur, Maharashtra, India – 416001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Oxalis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oxalis Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Oxalis Pharmaceuticals Private Limited, buy the company report.
Financials of Oxalis Pharmaceuticals Private Limited
FY 2025 filings availableOxalis Pharmaceuticals Private Limited reported revenue of ₹1.08 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 79% over five years, including 9% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.5% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oxalis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oxalis Pharmaceuticals Private Limited
Oxalis Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vardhan Mahaveer Deshmane | Director | 22 May 2012 | 14 Years 5 Months | Current |
| Mina Mahavir Deshmane | Director | 01 Nov 2012 | 13 Years 11 Months | Current |
Auditor
Oxalis Pharmaceuticals Private Limited is audited by BBCP & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BBCP & ASSOCIATES | FY 2024 | 126822W |
Shareholding
The shareholding of Oxalis Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Oxalis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Mar 2016 | 100068945 | Bank of India | ₹4 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Oxalis Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Oxalis Pharmaceuticals. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kolhapur, Maharashtra | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Oxalis Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oxalis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oxalis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCO6569N1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Oxalis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oxalis Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Mina Mahavir Deshmane was appointed as Director on 01 Nov 2012.
Frequently asked questions
Oxalis Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 May 2012 (14+ years old) and is registered under CIN U24232PN2012PTC143462.
Oxalis Pharmaceuticals has 2 current directors:
- Vardhan Mahaveer Deshmane - Director
- Mina Mahavir Deshmane - Director
The latest financial statements of Oxalis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Oxalis Pharmaceuticals is 27AABCO6569N1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Oxalis Pharmaceuticals is U24232PN2012PTC143462. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxalis Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Oxalis Pharmaceuticals was incorporated on 22 May 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
Mina Mahavir Deshmane was appointed as Director on 01 Nov 2012. Shailendrakumar Balaso Kore ceased to be Director on 01 Nov 2012. Suresh Shankar Jabade ceased to be Director on 01 Nov 2012. Oxalis Pharmaceuticals has 4 board changes on record in total.
Oxalis Pharmaceuticals can be reached through the website oxalispharmaceuticals.com. Its registered office is in Kolhapur, Maharashtra, India.
The registered office of Oxalis Pharmaceuticals is at Cs No 5841A – 2 Ground Floor Gala No 2 Office 1st Lane E Ward Sh, Ahupuri, Kolhapur, Maharashtra, India – 416001.